Skip to content

 

The following delegates have already registered to attend OIS@ASRS.  Sign up today to be added to this growing list!

A

AccelLAB
Francois Bergeron, MSc, Director Business Development

Alimera Sciences
Antonio Cutino, VP, Medical Affairs
Rick Eiswirth, President & CEO
Samer Kaba, Chief Medical Officer

Acucela
John Shishilla, SVP, Retinal Health Monitoring

Adverum Biotechnologies
Sandipan Bagchi, Executive Director, Business Development
Mehdi Gasmi, President & Chief Scientific Officer
Claire Gelfman, VP, Pharmaceutical Development
Carol Hoang-Roller, VP, Medical Affairs
Adam Turpcu, Director, Clinical Sciences
Jason Wang, Senior Manager, Corporate Strategy & Investor Relations

Aerie Pharmaceuticals
Vince Anido, PhD, Chairman & CEO
Ami Bavishi, Investor Relations
Eric Carlson, VP, Head, R&D
Gianluca Corbinelli, Chief Commercial Officer, Europe
Tad Heitmann, MBA, Director, Corporate Communications
Casey Kopczynski, PhD, Chief Scientific Officer
Cheng-Wen Lin, Director, Drug Delivery & Pharmacology
Mike McCleerey, VP, Portfolio Development

AffaMed Therapeutics
MaryJane Rafii, PhD, MBA, Senior Vice President

Alcon
Ravi Durvasula, PhD, Retinal Surgical Instrumentation R&D
Wesley Elden, Global Product Director, Surgical Retina
Paul Hallen, Global Head, Surgical Vitreoretinal & Glaucoma
Patrick Matthews, Head, BD&L Transactions
Patrick Sadd, Global Director, CAT Marketing
Matthew Snakenberg, Head, Global BD&L and M&A
Jay Stark, Global Head, Surgical Visualization

Alkahest
Elizabeth Jeffords, Chief Commercial & Strategy Officer
Erin Newman, VP, Program Development
Esther Rawner, MD, Medical Director

All Eyes Consulting
Namrata Saroj, OD, Director

Allegro Ophthalmics
Scott Cooper, CFO
Hampar Karageozian, Executive Chairman
Vicken Karageozian, MD, President & CEO
John Park, PhD, Chief Scientific Officer & VP, Mfg Development

Allergan
Doug Faunce, PhD, Executive Director, External Science & Innovation
Jai Parekh, MD, MBA, FAAO, Chief Medical Officer & VP
Chuck Silberstein, MD, Senior Vice President

Alpine Biotherapeutics
Keith Bryant, Business Adviser

Aptitude Medical Systems
Scott Ferguson, CEO
Jackson Gong, COO

AsclepiX Therapeutics
Julia Balanova, Investor Relations
Josh Barer, Board of Directors
Niranjan Pandey, PhD, VP & Head, R&D
Wendy Perrow, MBA, CEO
Kevin Slawin, Board of Directors

Astellas Pharma
Tomoaki Yoshikawa, PhD, Manager, Senior Researcher

Austin Retina Associates
Robert Wong, MD, Physician

Avanti
Samir Tari, MD, MBA, Principal

Avella Specialty Pharmacy
Jim Rehovsky, Vice President

B

Bascom Palmer
Audina Berrocal, MD

Bausch + Lomb
Nathan Belcher, Design Engineering Manager
Mike Bradley, Product Manager, Surgical Retina
David Fisher, VP, Marketing
Chuck Hess, VP & General Manager, US Surgical
Val Kolesnitchenko, MD, Senior Director Medical Affairs
Brent Lindsey, National Sales Director
Kristy Marks, Director, Corporate Communications
Robert Niemietz, Senior Director, Marketing
Andrew Pilon, OD, Director, Ophthalmic Implants
Calvin Roberts, MD, SVP, Chief Medical Officer, Eye Health

Bausch Health
Evan Hua, Senior Business Development Analyst
Sandeep Lalit, VP, Business Development

Bayer
Daniel Janer, MD, Global Medical Affairs
Steven Jones

Belite Bio
Irene Wang, COO

Biovisics Medical
Jim Chiapetta, CEO

Blackstone Life Sciences
Emmett Cunningham, MD, PhD, MPH, Senior Managing Director

BridgeBio
Houman Hemmati, MD, PhD, Clinical Development
Barrett Katz, MD, President & Chief Medical Officer
Sandy Mong, MD, VP, Business Development & Operations
Glenn Noronha, Chief Scientific Officer

Bryn Mawr Communications
Janet Burk, Publisher

BTIG
Ryan Zimmerman, Director, Equity Research Medical Technology

C

C-Bridge Capital
Michael Keyoung, MD, PhD, Managing Director & Head, North America

California Retina Consultants
Robert Avery, MD, Founder

Canaan Partners
Wende Hutton, General Partner

Carl Zeiss Meditec
Andrew Chang, Head, Global Sales, Ophthalmic Devices
Robert Gibson, Senior Director, Product Management
Kevin Langton, Global Director, Professional Education Ophthalmic Diagnostics
Niranchana Manivannan, PhD, Senior Staff Scientist, Clinical Research & Analytics Development
Angelo Rago, Global Head, Ophthalmic Diagnostics

Carolina Retina Center
Jeffrey Gross, MD, Founder & President

Cativer Bio Insights
Stephen Judd, President

Cell Care Therapeutics
Shannon Dahl, PhD, Chief Scientific Officer
Nicholas Sohl, CEO

Charles Retina Institute
Steve Charles, MD, Founder & Chairman

Chengdu Kanghong Pharmaceutical Group
Li Liu, PhD, Associate Director, Corporate Development
Fang Zhang, Corporate Development Manager

ChiralLogicJoshua Parks, Founder

Clarion Healthcare
Carol Kearney, Managing Director

Clearside Biomedical
Thomas Ciulla, MD, Chief Medical Officer
Charlie Deignan, CFO
Rick McElheny, VP, Corporate Development

Coherus Biosciences
Rajat Agrawal, SVP, Clinical Development - Ophthalmology

Colorado Retina Associates, PC
Alan Kimura, MD

Compact Imaging
Don Bogue, CEO

D

Dalton & Associates
Michelle Dalton

Drusolv Therapeutics
John Edwards, CEO

Duke Eye Center
Michael Allingham, MD, PhD, Assistant Professor of Ophthalmology
Priyatham Mettu, MD, Assistant Professor of Ophthalmology

E

Eloxx Pharmaceuticals
Susan Schneider, MD, SVP, Clinical Development, Ophthalmology

Ethis
Etani Fajardo, EVP & General Manager
Luca M. Sergio, CEO & Owner
Michael Smolinsky, Chief Content Officer

Evolve Medical Education
Alan Guralnick, President

Evolve Therapeutics
Donald Fishbein, President

ExSight Ventures
Firas Rahhal, MD, Partner

Eyedaptic
Jay Cormier, CEO

EyeGate Pharma
Stephen From, CEO

EyePoint Pharmaceuticals
Tom Hadley, VP, Marketing & Sales
Scott Jones, Chief Commercial Officer
Dario Paggiarino, MD, Chief Medical Officer
Keyur Patel, VP, Medical Affairs
Josh Pettit, National Sales Manager
Michelle Poole, Senior Director, Marketing
Joe Smith, Executive Director, Business Development

Eyevensys
Patricia Zilliox, CEO & President

F

ForSight Labs
K. Angela Macfarlane, Managing Partner

Foundation Fighting Blindess
Chris Adams, VP Marketing
David Brint, Chairman of the Board
Michele DiVincenzo, Senior Director, Events & Chapters
Ben Shaberman, Senior Director, Scientific Outreach & Community Engagement
Jason Menzo, Chief Operating Officer

G

Genentech
Amitabha Bhakta, PhD, MSL
Christopher Brittain, MRCOphth, MD, MBA, Global Head, Ophthalmology, Clinical Development
Hao Chen, PhD, Lead Clinical Scientist
Ann Clark, Associate Director
Daniela Ferrara, MD, MSc, PhD, Medical Director, Ophthalmology
Jasmine Hsieh, Marketing Manager
Jason Lin, PharmD, Senior Marketing Manager
Jeanie Nguyen, Manager, Market Analysis & Strategy
Carlos Quezada-Ruiz, MD
Rachel Retajczyk, Marketing
Min Tsuboi, Principal MSL
Andrew Villani, Associate Director, Corporate Relations

Glauconix Biosciences
George Torrejon, Senior Director, Operations & Business Development

Gray Communications
Michele Gray, Principal

Graybug Vision
Fred Guerard, CEO
Charles Semba, MD, Chief Medical Officer
Jin-Zhong Zhang, PhD, VP, Preclinical Development

Gyroscope Therapeutics
Susan Hill, PhD, Chief Business Officer

H

Heidelberg Engineering
Kfir Azoulay, VP & Head, Corporate Strategy

Horizon Therapeutics
Todd Lewis, Senior Director, Commercial Development

I

Illinois Retina Associates
John Pollack, MD, Partner

InFocus Capital Partners
Ron Weiss, MD, Managing Partner

InFocus Clinical
Brad Doerschuk, President & CEO

Interface Biologics
Wendy Naimark, PhD, VP, R&D

Istanbul Bilim University
Murat Oncel, MD, Professor, Ophthalmology

J

Janssen R&D
Penny Fleck, Global Head, Strategy, CVMTA
Hamish Ross, PhD, Senior Director, Alliance Management
James Tobin, PhD, Vice President

jCyte
Paul Bresge, CEO

Johns Hopkins Technology Ventures
Amy House, Associate Director, Corporate Partnerships

K

Kala Pharmaceuticals
Kim Brazzell, MD, PhD, Chief Medical Officer
Niranjan Kameswaran, VP, Strategy
Steven Zhang, MD, PhD, VP, Medical Affairs

KKR
Arjun Arora, Principal
Kal Rao, Associate

Kodiak Sciences
Jason Ehrlich, MD, PhD, Chief Medical Officer & Chief Development Officer
Victor Perlroth, MD, Founder & CEO

L

Lexitas
Chad Ice, CEO
Michael Schiewe, Director, Business & Site Development

Lifecore Biomedical
Kipling Thacker, PhD, Chief Scientific Officer & VP

M

Market Scope
Peter Downs, Writer & Analyst
William Freeman, Vice President

Media MICE
Matt Young, CEO & Publisher

Miami Ocular Oncology & Retina (MOOR)
Timothy Murray, MD, MBA, FACS, Founding Director & CEO

N

National Alliance Eye Vision Research
James Jorkasky, Executive Director

NEA
Ali Behbahani, MD, General Partner

Needham
Serge Belanger, Analyst

Nevakar
Raul Trillo, Chief Commercial Officer
Edward Tykot, VP, Business Development

New England Eye Center
Jay Duker, MD, Director

New York Retina and Macula Institute
Aryeh Pollack, MD, CEO

Notal Vision
Grace Chang, MD, PhD, Chief Medical Officer
Kester Nahen, Chief Commercial Officer
Susan Orr, OD, CEO

Novartis
Raghava Evuru

O

OcuFLOW
Theresa Kramer, MD, MBA, Ophthalmic Pathologist

Ocugenix
Sean McDonald, President & CEO

Oculis
Riad Sherif, CEO

Oculos Clinical Research
Ronil Patel, Business Development

Ocunexus Therapeutics
Brian Levy, OD, MSc, CEO

Ocuphire Pharma
Mina Sooch, MBA, CEO

Ocutrx
Victoria McArtor, Chief Communications Officer

Ocutrx Vision Technologies
Michael Freeman, CEO & Chief Technology Officer

OD-OS GmbH
Winfried Teiwes, CEO & Managing Director

OIS Weekly
Rich Kirkner

Omar Consulting Group
Cheryl Rowe-Rendleman, PhD, CEO & Managing Consultant

ONL Therapeutics
David Esposito, CEO

Ophthalmology Times
Sheryl Stevenson, Group Editorial Director

Optceutics
Christopher Redhead, PhD, CEO

Opthea Limited
Megan Baldwin, PhD, Managing Director & CEO

Optos
Anne Marie Cairns, Chief Clinical Officer

Ora
Sanjeev Ganatra, Director, Business Development
Jeanne Hecht, Chief Strategy Officer
Lisa Jennings, Senior Director, Global Alliance Business Development
Richie Kahn, Director, Business Development
Josh Moriarty, Executive Director, Business Development
Aron Shapiro, SVP & Chief Commercial Officer
Stewart Sylvester, Business Development

Outlook Therapeutics
Terry Dagnon, COO
Jeff Evanson, Chief Commercial Officer
Jennifer Kissner, PhD, SVP, Clinical Development

OXURION NV
Andy De Deene, MD, Global Head, Development
Patrik De Haes, MD, CEO
Jean Feyen, PhD, Chief Scientific Officer
Gregoire Franoux, Head, Business Development & Licensing
Petra Kozma-Wiebe, MD, Director, Global Clinical Development
Wouter Piepers, Head, Corporate Communications & Investor Relations

P

Panoptes Pharma
Franz Obermayr, CEO

PanOptica
Paul Chaney, President & CEO
Martin Wax, MD, EVP, R&D & Chief Medical Offier

Patterson Thuente
Paul Onderick, OD, JD, Eye Doctor & Patent Attorney

PentaVision
Jennifer Ford, Senior Managing Editor, Retinal Physician & Glaucoma Physician Magazines

PharM&A Advisors
Philip Gioia, Managing Director

PhotoOpTx
Mike Judy, Board Member
Tom Kelly, CEO
Jeffrey Lenk, Chief Technology Officer

Piper Jaffray
Ryan Kaeding, Director
Mihir Mantri, Managing Director

Pivotal bioVenture Partners
Ash Khanna, PhD, Venture Partner

PolyActiva
Russell Tait, CEO

Powered Research
Chris Brasfield, Director, Business Development

Pr3vent
Jochen Kumm, Founder
Darius Moshfeghi, MD, Founder

Promedica International
Khan Lau, OD, MBA, Director, Clinical Operations

R

Regenera Pharma
Jordan Rubinson, CEO

Regeneron
Keith Baker, MD, Medical Director, Ophthalmology Medical Affairs
Abby Cahn, Director CBU Operational Effectiveness
Kevin Clark, Exeuctive Director Marketing
Emmanuel Hamon, Senior Director, Marketing - Diabetic Retinopathy
Vicky Jones
Darren Kwok, Associate Director Corporate Communications
John Magliocchetti, Senior Director, Marketing
Stephen Marshall, Strategic Analysis
David Scisciani, TLL
Michael Suesserman, VP, CBU Head, Ophthalmology

REGENXBIO
Paulo Falabella, MD, PhD, VP, Clinical Development
Rei Nakamura, PhD, Senior MSL
Steve Pakola, MD, SVP & Chief Medical Officer
Ram Palanki, SVP, Commercial Strategy & Operations
Sherri Van Everen, VP Clinical Development
Jesse Yoo, Senior Surgical Trainer

Retina Associates of Cleveland
Lawrence J. Singerman, MD, FACS, Founder

Retina Today
Michele Corry, Assistant Editor
Scott Krzywonos, Editor-in-Chief

Retina-Vitreous Associates Medical Group
David Boyer, MD

Retinal Consultants of Arizona
Pravin Dugel, MD, Managing Partner

Retinal Solutions
Scott Olson, CEO

Re-Vana Therapeutics
Michael Nash, Chief Commercial Officer
Michael O'Rourke, President & CEO

Review of Ophthalmology/Review of Optometry
Michele Barrett, Manager

Rimonci
Richel Liu, CEO

Roche Genentech
Yawen Chiang, PhD, Director, Product Optimization Lead

RTW Investments
Gotham Makker, Consultant, Strategic Investments
Steve Saland, Research Manager

Rush University
Pauline Merrill, MD, Section Director, Uveitis

S

Santen
Jean Kim, Venture Capital Analyst

SciFluor Life Sciences
Scott Edwards, PhD, VP & General Manger

Shire (A Takeda Company)
Susan Benton, Head, New Ophthalmic Products
Beth Marsh, Global Product Strategy Lead

SparingVision
Florence Allouche, PharmaD, CEO

Spark Therapeutics
Frank Nazzario, US Marketing Leader

Stargazer Pharmaceuticals
Gary Sternberg, MD, CEO

Stealth BioTherapeutics
Irene McCarthy, CEO
Brian Hotchkiss, Head, Business Development & New Product Planning

Syneos Health
Nicholas Spittal, SVP, Clinical Development

T

Takeda Pharmaceutical
Kim Paes, Clinical Development Scientist

Texere Publishing
Neil Hanley, Publisher

TFG Education
Brad Fundingsland, President
Rebecca Winter, Global Business Development

TGP Communications
Teresa Panas, Principal

Torreya
Anna Makki, Managing Director

Tracery Ophthalmics
Chris Bott, Senior Adviser
Shelley Boyd, MD, President & CEO

Trial Runners
Brandon Beaudoin, Director, Clinical Development
Patrick Healy, MPH, Co-Founder, Executive Chairman
Cameron Marshall, Business Development Director

U

University Hospital Bern
Marion Munk, MD, PhD

University of California, Davis
Glenn Yiu, MD, PhD, Associate Professor

University of California, Irvine
Baruch Kuppermann, MD, PhD, Steinert Professor and Chair, Department of Ophthalmology, Gavin Herbert Eye Institute

University of Pittsburgh School of Medicine
José Sahel, MD, Chair, Department of Ophthalmology and The Eye & Ear Foundation Endowed Chair

University of Southern California
Mark Humayun, MD, PhD, Professor, Ophthalmology

UPMC Enterprises
Alexander Anetakis, MD, Physician Advisor

USC Keck School of Medicine, USC Eye Institute
Linda Lam, MD, MBA

V

Valley Retina Institute
Victor Gonzalez, MD, CEO

Verana Health
Bill Abbott, Business Development Executive - Clinical Trials
Chet Kumar, VP, Life Science & Commercial

Vestrum Health
Nadeem Ahmad, COO

Visant Medical
Vartan Ghazarossian, President & CEO

Vision Ophthalmic Development International
Rhett Schiffman, MD, MS, MHSA, President & CEO

Visionary Venture Fund
Garett Hamontree, Principle

VisionCare
Blake Michaels, President & CEO

Vitreous Retina Macula Specialists of Toronto
Netan Choudhry, MD, Founder & Medical Director

W

Warrenville EyeCare & LASIK
Lisa Nijm, MD, JD, Founder & Medical Director

Wave Life Sciences
Michael Byrne, PhD, Director in Vivo Biology & Ophthalmology

Weill Cornell Medicine
Szilard Kiss, MD, Director, Clinical Research & Chief, Retina Service

Windsor Laser Eye Institute, Kresge Eye Institute
Pradeepa Yoganathan, MD, Assistant Professor

#

21GRAMS
Justin LaMonica, VP, Strategy

2CTech
James Taylor, CEO

 

Stacy Evans, MD

Scroll To Top